Chapter 44

  1. Anah MU, Udo JJ, Ochigbo Som, et al. 2008. Neonatal septicaemia in Calabar, Nigeria. Trop Doct 38:126-128.
  2. Anzai Y, Kudo Y, Oyaizu H. 1997. The phylogeny of the genera Chryseomonas, Flavimonas, and Pseudomonas supports the synonymy of these three genera. Int J Syst Bacteriol 47:249-251.
  3. Baker S, Campbell JI, Stabler R, et al. 2008. Fatal wound infections caused by Chromobacterium violaceum in Ho Chi Minh City, Vietnam. J Clin Microbiol 46:3853-3855.
  4. Bauernfeind A, Roller C, Meyer D, et al. 1998. Molecular procedure for rapid detection of Burkholderia mallei and Burkholderia pseudomallei. J Clin Microbiol 36:2737-2741.
  5. Biberstein EL, Holzworth J. 1987. Bacterial diseases: glanders. In Holzworth J (ed): Diseases of the cat: medicine and surgery. WB Saunders, Philadelphia.
  6. Bosch FJ, Badenhorst L, Le Roux JA, et al. 2008. Successful treatment of Chromobacterium violaceum sepsis in South Africa. J Med Microbiol 57:1293-1295.
  7. Brett PJ, Woods DE. 2000. Pathogenesis of and immunity to melioidosis. Acta Trop 74:201-210.
  8. Brook MD, Currie B, Desmarchelier PM. 1997. Isolation and identification of Burkholderia pseudomallei from soil using selective culture techniques and the polymerase chain reaction. J Appl Microbiol 82:589-596.
  9. Casalta JP, Fournier PE, Habib G, et al. 2005. Prosthetic valve endocarditis caused by Pseudomonas luteola. BMC Infect Dis 5:82.
  10. Centers for Disease Control and Prevention. 2008. Bioterrorism agents/diseases (by category). Emergency preparedness and response. www.bt.cdc.gov/agent/agentlist-category.asp. Accessed 1/25/10.
  11. Chantratita N, Meumann E, Thanwisai A, et al. 2008. Loop-mediated isothermal amplification method targeting the TTS1 gene cluster for detection of Burkholderia pseudomallei and diagnosis of melioidosis. J Clin Microbiol 46:568-573.
  12. Chantratita N, Wuthiekanun V, Limmathurotsakul D, et al. 2007. Prospective clinical evaluation of the accuracy of 16S rRNA real-time PCR assay for the diagnosis of melioidosis. Am J Trop Med Hyg 77:814-817.
  13. Chaowagul W. 1996. Melioidosis: a treatment challenge. Scand J Infect Dis 101(Suppl):14-16.
  14. Chaowagul W. 2000. Recent advances in the treatment of severe melioidosis. Acta Trop 74:133-137.
  15. 14a. Cheng AC. 2010. Melioidosis: advances in diagnosis and treatment. Curr Opin Infect Dis 23:554-559.
  16. Cheng AC, Stephens DP, Ansley NM, et al. 2004. Adjunctive granulocyte colony-stimulating factor for treatment of shock due to melioidosis. Clin Infect Dis 38:32-37.
  17. Cheng AC, Currie BJ. 2005. Melioidosis: epidemiology, pathophysiology, and management. Clin Microbiol Rev 18:383-416.
  18. Cheng AC, Godoy D, Mayo M, et al. 2004. Isolates of Burkholderia pseudomallei from Northern Australia are distinct by multilocus sequence typing, but strain types do not correlate with clinical presentation. J Clin Microbiol 42:5477-5483.
  19. Cheng AC, Ward L, Godoy D, et al. 2008. Genetic diversity of Burkholderia pseudomallei isolates in Australia. J Clin Microbiol 46, 249-254.
  20. Chihab W, Alaoui AS, Amar M. 2004. Chryseomonas luteola identified as the source of serious infections in a Moroccan University Hospital. J Clin Microbiol 42:1837-1839.
  21. Chooi KF, Omar AR, Lee JYS. 1982. Melioidosis in a domestic cat, with concurrent infestation by nymphs of the cat pentastome, Armillifer moniliformis. Kajian Vet 14:41-43.
  22. Crosse PA, Soares K, Wheeler JL, et al. 2006. Chromobacterium violaceum infection in two dogs. J Am Anim Hosp Assoc 42:154-159.
  23. Currie BJ. 2008. Advances and remaining uncertainties in the epidemiology of Burkholderia pseudomallei and melioidosis. Trans R Soc Trop Med Hyg 102:225-227.
  24. Currie BJ, Fisher DA, Howard DM, et al. 2000. Endemic melioidosis in tropical northern Australia: a 10-year prospective study and review of the literature. Clin Infect Dis 31:981-986.
  25. Currie BJ, Jacups SP. 2003. Intensity of rainfall and severity of melioidosis, Australia. Emerg Infect Dis 9:1538-1542.
  26. Dalamaga M, Karmaniolas K, Chavelas C, et al. 2004. Pseudomonas luteola cutaneous abscess and bacteraemia in a previously healthy man. Scand J Infect Dis 36:495-497.
  27. Dharakul T, Songsivilai S, Viriyachitra S, et al. 1996. Detection of Burkholderia pseudomallei DNA in patients with septicemic melioidosis. J Clin Microbiol 34:609-614.
  28. Fantinatti-Garboggini F, Almeida RD, Portillo VDA, et al. 2004. Drug resistance in Chromobacterium violaceum. Genet Mol Res 3:134-147.
  29. Dvorak GD, Spickler AR. 2008. Glanders. J Am Vet Med Assoc 233:570-577.
  30. 28a. Estes DM, Dow SW, Schweizer HP, et al. 2010. Present and future therapeutic strategies for melioidosis and glanders. Expert Rev Anti Infect Ther 8:325-338.
  31. 28b. Galyov EE, Brett PJ, DeShazer D. 2010. Molecular insights into Burkholderia pseudomallei and Burkholderia mallei pathogenesis. Ann Rev Microbiol 64:495-517.
  32. Ghosh SK. 2000. A rare infection caused by Chryseomonas luteola. J Infect 41:109-110.
  33. Gogolewlski RP. 1983. Chromobacterium violaceum septicaemia in a dog. Aust Vet J 60:226.
  34. Greene CE. 1990. Enteric and other bacterial infections, pp 553-554. In Greene CE (ed): Infectious diseases of the dog and cat, ed 1. WB Saunders, Philadelphia.
  35. Godoy D, Randle G, Simpson AJ, et al. 2003. Multilocus sequence typing and evolutionary relationships among the causative agents of melioidosis and glanders, Burkholderia pseudomallei and Burkholderia mallei. J Clin Microbiol 41:2068-2079.
  36. Hawkins E, Moriarty RA, Lewis DE, et al. 1991. Serious infections involving the CDC group Ve bacteria Chryseomonas luteola and Flavimonas oryzihabitans. Rev Infect Dis 13:257-260.
  37. Haase A, Brennan M, Barrett S, et al. 1998. Evaluation of PCR for diagnosis of melioidosis. J Clin Microbiol 36:1039-1041.
  38. Heine HS, England MJ, Waag DM, et al. 2001. In vitro antibiotic susceptibilities of Burkholderia mallei (causative agent of glanders) determined by broth microdilution and E-test. Antimicrob Agents Chemother 45: 2119-2121.
  39. 35a. Hornstra H, Pearson T, Georgia S, et al. 2009. Molecular epidemiology of glanders, Pakistan. Emerg Infect Dis 15:2036-2039.
  40. Inglis TJ, Rolim DB, Rodriguez JL. 2006. Clinical guideline for diagnosis and management of melioidosis. Rev Inst Med Trop Sao Paulo 48:1-4.
  41. Iridis A, Rachmat RFN, Ali SMM. 1998. Melioidosis: a case of sheep to human transmission. J Vet Malaysia 10:77-79.
  42. Jayagopal S, Berry MG, Ross G, et al. 2004. Hand infections caused by Chryseomonas luteola. Br J Plast Surg 57:694-695.
  43. 38a. Judy BM, Whitlock GC, Torres AG, et al. 2009. Comparison of the in vitro and in vivo susceptibilities of Burkholderia mallei to ceftazidime and levofloxacin. BMC Microbiol 9:88.
  44. Kenny DJ, Russell P, Rogers D, et al. 1999. In vitro susceptibilities of Burkholderia mallei in comparison to those of other pathogenic Burkholderia spp. Antimicrob Agents Chemother 43:2773-2775.
  45. 39a. Kenny DJ, Sefton AM, Brooks TJG, et al. 2010. Evaluation of azithromycin, trovafloxacin and grepafloxacin as prophylaxis for experimental murine melioidosis. Int J Antimicrob Agents 36:87-89.
  46. Keskin O, Ilhan Z. 2000. Isolation of Pseudomonas mallei from a dog. Vet Fakultesi Dergisi, Ankara Univ 47:13-16.
  47. Ketheesan N, Barnes JL, Ulett GC. 2002. Demonstration of a cell-mediated immune response in melioidosis. J Infect Dis 186:286-289.
  48. Kostman JR, Solomon F, Fekete T. 1991. Infections with Chryseomonas luteola (CDC group Ve-1) and Flavimonas oryzihabitans (CDC group Ve-2) in neurosurgical patients. Rev Infect Dis 13:233-236.
  49. 42a. Larsen JC, Johnson NH. 2009. Pathogenesis of Burkholderia pseudomallei and Burkholderia mallei. Mil Med 174:647-651.
  50. Leelarasamee A, Bovornkitti S. 1989. Melioidosis: review and update. Rev Infect Dis 11:413-425.
  51. Lloyd JM, Suijdendorp P, Soutar WR. 1988. Melioidosis in a dog. Aust Vet J 65:191-192.
  52. Low Choy J, et al. 2000. Animal melioidosis in Australia. Acta Trop 74:153-158.
  53. McCombie RL, Finkelstein RA, Woods DE. 2006. Multilocus sequence typing of historical Burkholderia pseudomallei isolates collected in Southeast Asia from 1964 to 1967 provides insight into the epidemiology of melioidosis. J Clin Microbiol 44:2951-2962.
  54. Merianos A, Patel M, Lane JM, et al. 1993. The 1990-1991 outbreak of melioidosis in the Northern Territory of Australia: epidemiology and environmental studies. Southeast Asian J Trop Med Public Health 24:425-435.
  55. Neuber AE, van den Broek AH, Brownstein D, et al. 2004. Dermatitis and lymphadenitis resembling juvenile cellulitis in a four-year-old dog. J Small Anim Pract 45:254-258.
  56. Neuber AE, van den Broek AH, Brownstein D, et al. 2004. Dermatitis and lymphadenitis resembling juvenile cellulitus in a 4-year-old dog. J Small Anim Pract 45:254-258.
  57. Ngauy V, Lemeshev Y, Sadkowski L, et al. 2005. Cutaneous melioidosis in a man who was taken as a prisoner of war by the Japanese during World War II. J Clin Microbiol 43:970-972.
  58. O’Brien CR, et al. 2003. Disseminated melioidosis in two cats. J Fel Med Surg 5:83-89.
  59. O’Brien CR, Greene CE, Greene RT. 2006. Miscellaneous bacterial infections, pp 436-438. In Greene CE (ed): Infectious diseases of the dog and cat, ed 3. Elsevier, Philadelphia.
  60. Parkes H, Shilton C, Jerrett I, et al. 2009. Primary ocular melioidosis due to a single genotype of Burkholderia pseudomallei in two cats from Arnhem Land in the Northern Territory of Australia. J Fel Med Surg 11:856-863.
  61. Ponte R, Jenkins SG. 1992. Fatal Chromobacterium violaceum infections associated with exposure to stagnant waters. Pediatr Infect Dis J 11:583-586.
  62. Rahav G, Simhon A, Mattan Y, et al. 1995. Infections with Chryseomonas luteola (CDC group Ve-1) and Flavimonas oryzihabitans (CDC group Ve-2). Medicine 74:83-88.
  63. Rajchanuvong A, Chaowagul W, Suputtamongkol Y, et al. 1995. A prospective comparison of co-amoxiclav and the combination of chloramphenicol, doxycycline, and co-trimoxazole for the oral maintenance treatment of melioidosis. Trans R Soc Trop Med Hyg 89:546-549.
  64. 56a. Ramana KV, Kareem MA, Sarada CHV, et al. 2002. Chryseomonas luteola bacteremia in a patient with left pyocele testis with Fournier's scrotal gangrene. Indian J Pathol Microbiol 53:574-575.
  65. Rastogi S, Sperber SJ. 1998. Facial cellulitis and Pseudomonas luteola bacteremia in an otherwise healthy patient. Diagn Microbiol Infect Dis 32:303-305.
  66. Rattanathongkom A, Sermswan RW, Wongratanacheewin S. 1997. Detection of Burkholderia pseudomallei in blood samples using polymerase chain reaction. Mol Cell Probes 11:25-31.
  67. Read KM, Currie B, McDonald P, et al. 2001. Reactivation of latent melioidosis in association with staphylococcal endocarditis. Intern Med J 31:130-131.
  68. Russell P, Eley SM, Ellis J, et al. 2000. Comparison of efficacy of ciprofloxacin and doxycycline against experimental melioidosis and glanders. J Antimicrob Chemother 45:813-818.
  69. 60a. Schmoock G, Ehricht R, Melzer F, et al. 2009. DNA microarray-based detection and identification of Burkholderia pseudomallei and Burkholderia spp. Mol Cell Probes 23:178-187.
  70. Sneath PH. 1956. Cultural and biochemical characteristics of the genus Chromobacterium. J Gen Microbiol 15:70-98.
  71. Srinivasan A, Kraus CN, Deshazer D, et al. 2001. Glanders in a military research microbiologist. N Engl J Med 345:256-258.
  72. Stedham MA. 1977. Histopathology of melioidosis in the dog. Lab Invest 36:358.
  73. Stewart CE. 2006. Live bacterial agents, pp 99. In Weapons of mass casualties and terrorism response handbook. Jones and Bartlett, Sudbury, MA.
  74. Teoh AYB, Hui M, Ngo KY, et al. 2006. Fatal septicaemia from Chromobacterium violaceum: case reports and review of the literature. Hong Kong Med J 12:228-231.
  75. Thibault FM, Hernandez E, Vidal DR, et al. 2004. Antibiotic susceptibility of 65 isolates of Burkholderia pseudomallei and Burkholderia mallei to 35 antimicrobial agents. J Antimicrob Chemother 54:1134-1138.
  76. Toh IH, Heng HG, Zamri-Saad M, et al. 1998. Melioidosis in a kitten. J Vet Malaysia 10:73-76.
  77. White NJ. 2003. Melioidosis. Lancet 361:1715-1722.
  78. Wong KT, Vadivelu J, Puthucheary SD, et al. 1996. An immunohistochemical method for the diagnosis of melioidosis. Pathology 28:188-191.
  79. Woods DE, DeShazer D, Moore RA, et al. 1999. Current studies on the pathogenesis of melioidosis. Microbes Infect 1:157-162.
  80. World Organization for Animal Health. 2008. Diseases notifiable to the OIE. www.oie.int/eng/maladies/en_classification2007.htm. Accessed 12/22/08.